Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii

International Journal of Antimicrobial Agents

Volumn 32, Issue 3, 2008, Pages 281-284

  Song, Joon Young ^a   Lee, Jacob ^a   Heo, Jung Yeon ^a   Noh, Ji Yun ^a   Kim, Woo Joo ^a   Cheong, Hee Jin ^a   Hwang, In Sook ^b  

^a Kyung Hee University Hospital   (South Korea)

^b Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEFOTIAM; CEFTAZIDIME; CEFTIZOXIME; COLISTIMETHATE; IMIPENEM; ISEPAMICIN; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; AGAR DILUTION; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; DISK DIFFUSION; DRUG EFFICACY; DRUG SAFETY; DRUG SENSITIVITY; EPSILOMETER TEST; HUMAN; HYPOMAGNESEMIA; LETTER; LIVER FUNCTION TEST; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SIDE EFFECT; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; CARBAPENEMS; COLISTIN; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; RIFAMPIN; TREATMENT OUTCOME;

EID: 49749141456     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.04.013     Document Type: Letter

References (7)

1. Poirel L., and Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12 (2006) 826-836
2. Lortholary O., Fagon J.Y., Hoi A.B., Slama M.A., Pierre J., Giral P., et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 20 (1995) 790-796
3. Montero A., Ariza J., Corbella X., Domenech A., Cabellos C., Ayats J., et al. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. J Antimicrob Chemother 54 (2004) 1085-1091
4. Li J., Rayner C.R., Nation R.L., Owen R.J., Spelman D., Tan K.E., et al. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 50 (2006) 2946-2950
5. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 7th ed. Approved standard. Document M7-A7. Wayne PA: CLSI; 2006.
6. Reina R., Estenssoro E., Sáenz G., Canales H.S., Gonzalvo R., Vidal G., et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med 31 (2005) 1058-1065
7. Saballs M., Pujol M., Tubau F., Peña C., Montero A., Domínguez M.A., et al. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections. J Antimicrob Chemother 58 (2006) 697-700